Katie Adams –
Thursday, September 3rd, 2020
Prescriptions for hydroxychloroquine, the malaria drug promoted by President Donald Trump as a potential COVID-19 treatment during the early months of the pandemic, shot up by 59 percent throughout March and April, according to a Sept. 3 report from the Centers for Disease Control and Prevention.
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by clicking here.
More short articles on pharmacy:2 nd FDA appointee ousted as agency faces criticism from medical communityEli Lilly stops offering 340B discount rates to contract pharmacies5 demands biotech CEOs have for their peers, the FDA regarding COVID-19 vaccine development.
Hydroxychloroquine has actually made regular looks in national headings throughout the pandemic as the medical neighborhood and federal government had a hard time to develop a cohesive viewpoint on the drugs efficiency in dealing with COVID-19.
The report likewise exposed that nonroutine prescribers– workers who are not medical care physicians who would typically prescribe the drug– wrote more than 75,000 prescriptions for hydroxychloroquine or chloroquine, its sibling drug, in March. That accounts for a 6,511 percent boost in hydroxychloroquine and chloroquine prescriptions composed by that group from February..
The CDC report exposed that more than 1.3 million prescriptions were composed for hydroxychloroquine in March and April, compared to nearly 820,000 throughout the very same duration in 2019.
The nonroutine prescribing specializeds with the largest hydroxychloroquine prescription volume increase in March were ophthalmology, anesthesiology and cardiology, according to the agency.